These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1324274)

  • 21. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Captopril attenuates diuretic and natriuretic actions of furosemide but not atrial natriuretic peptide.
    Di Nicolantonio R; Morgan TO
    Clin Exp Hypertens A; 1987; 9(1):19-32. PubMed ID: 2953509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
    Salerno F; Badalamenti S; Moser P; Lorenzano E; Incerti P; Dioguardi N
    Gastroenterology; 1990 Apr; 98(4):1063-70. PubMed ID: 2138104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized comparison of metoclopramide and domperidone on plasma aldosterone concentration and on spironolactone-induced diuresis in ascitic cirrhotic patients.
    D'Arienzo A; Ambrogio G; Di Siervi P; Perna E; Squame G; Mazzacca G
    Hepatology; 1985; 5(5):854-7. PubMed ID: 4029895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diminution by captopril of the diuretic, natriuretic and kallikrein stimulating action of furosemide by reduction in its renal secretion.
    Bönner G; Gentges A; Wambach G; Kaufmann W
    Agents Actions Suppl; 1987; 22():309-19. PubMed ID: 3324714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
    Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P
    Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion.
    Knauf H; Wenk E; Schölmerich J; Goerg KJ; Gerok W; Leser HG; Mutschler E
    Klin Wochenschr; 1990 Jun; 68(11):545-51. PubMed ID: 2198378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
    Fogel MR; Sawhney VK; Neal EA; Miller RG; Knauer CM; Gregory PB
    J Clin Gastroenterol; 1981; 3 Suppl 1():73-80. PubMed ID: 7035545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
    Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
    Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma atrial natriuretic peptide and renin-aldosterone in patients with cirrhosis and ascites: basal levels, changes during daily activity and nocturnal diuresis.
    Panos MZ; Anderson JV; Payne N; Langley P; Slater JD; Rees L; Williams R
    Hepatology; 1992 Jul; 16(1):82-8. PubMed ID: 1535609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
    Fernández-Esparrach G; Guevara M; Sort P; Pardo A; Jiménez W; Ginès P; Planas R; Lebrec D; Geuvel A; Elewaut A; Adler M; Arroyo V
    J Hepatol; 1997 Mar; 26(3):614-20. PubMed ID: 9075669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
    Am J Cardiol; 1996 Oct; 78(8):902-7. PubMed ID: 8888663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excess diuresis and natriuresis during acute sleep deprivation in healthy adults.
    Kamperis K; Hagstroem S; Radvanska E; Rittig S; Djurhuus JC
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F404-11. PubMed ID: 20519376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine changes associated with a rapidly developing sodium appetite in rats.
    Thunhorst RL; Morris M; Johnson AK
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1168-73. PubMed ID: 7977842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failure.
    Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
    Int J Cardiol; 1991 Dec; 33(3):377-83. PubMed ID: 1761331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.